Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Benztropine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for benztropine mesylate?

Benztropine mesylate is the generic ingredient in two branded drugs marketed by Upsher-smith Labs, Oxford Pharms, Quantum Pharmics, Usl Pharma, Aspen Global Inc, Oak Pharms Akorn, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Corepharma, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, Merck, and Invagen Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for benztropine mesylate. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: benztropine mesylate

Tradenames:2
Patents:1
Applicants:18
NDAs:31
Drug Master File Entries: see list5
Suppliers / Packagers: see list34
Bulk Api Vendors: see list62
Clinical Trials: see list180
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:benztropine mesylate at DailyMed

Pharmacology for Ingredient: benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
COGENTIN
benztropine mesylate
TABLET;ORAL009193-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Quantum Pharmics
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088511-001Jan 31, 1984DISCNNoNo► Subscribe► Subscribe
Leading Pharma Llc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL090168-002Nov 28, 2012RXNoNo► Subscribe► Subscribe
Hikma Farmaceutica
BENZTROPINE MESYLATE
benztropine mesylate
INJECTABLE;INJECTION090287-001Aug 31, 2009RXNoNo► Subscribe► Subscribe
Leading Pharma Llc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL090168-001Nov 28, 2012RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc